The Expanding Spectrum of FLNC Cardiomyopathy
Author Contributions
Funding
Conflicts of Interest
References
- Geisterfer-Lowrance, A.A.; Kass, S.; Tanigawa, G.; Vosberg, H.P.; McKenna, W.; Seidman, C.E.; Seidman, J.G. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 1990, 62, 999–1006. [Google Scholar] [CrossRef]
- Celeghin, R.; Cipriani, A.; Bariani, R.; Bueno Marinas, M.; Cason, M.; Bevilacqua, M.; De Gaspari, M.; Rizzo, S.; Rigato, I.; Da Pozzo, S.; et al. Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death. Heart Rhythm. 2022, 19, 235–243. [Google Scholar] [CrossRef]
- Ortiz-Genga, M.F.; Cuenca, S.; Dal Ferro, M.; Zorio, E.; Salgado-Aranda, R.; Climent, V.; Padrón-Barthe, L.; Duro-Aguado, I.; Jiménez-Jáimez, J.; Hidalgo-Olivares, V.M.; et al. Truncating FLNC Mutations Are Associated with High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J. Am. Coll. Cardiol. 2016, 68, 2440–2451. [Google Scholar] [CrossRef] [PubMed]
- Ader, F.; De Groote, P.; Réant, P.; Rooryck-Thambo, C.; Dupin-Deguine, D.; Rambaud, C.; Khraiche, D.; Perret, C.; Pruny, J.F.; Mathieu-Dramard, M.; et al. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations. Clin. Genet. 2019, 96, 317–329. [Google Scholar] [CrossRef]
- Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; Hegde, M.; Lyon, E.; Spector, E.; et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17, 405–424. [Google Scholar] [CrossRef] [Green Version]
- Brodehl, A.; Ferrier, R.A.; Hamilton, S.J.; Greenway, S.C.; Brundler, M.A.; Yu, W.; Gibson, W.T.; McKinnon, M.L.; McGillivray, B.; Alvarez, N.; et al. Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy. Hum Mutat. 2016, 37, 269–279. [Google Scholar] [CrossRef] [PubMed]
- Razinia, Z.; Mäkelä, T.; Ylänne, J.; Calderwood, D.A. Filamins in mechanosensing and signaling. Annu. Rev. Biophys. 2012, 41, 227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- González-Morales, N.; Holenka, T.K.; Schöck, F. Filamin actin-binding and titin-binding fulfill distinct functions in Z-disc cohesion. PLoS Genet. 2017, 13, e1006880. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Monda, E.; Caiazza, M.; Limongelli, G. The Expanding Spectrum of FLNC Cardiomyopathy. Cardiogenetics 2022, 12, 276-277. https://doi.org/10.3390/cardiogenetics12040027
Monda E, Caiazza M, Limongelli G. The Expanding Spectrum of FLNC Cardiomyopathy. Cardiogenetics. 2022; 12(4):276-277. https://doi.org/10.3390/cardiogenetics12040027
Chicago/Turabian StyleMonda, Emanuele, Martina Caiazza, and Giuseppe Limongelli. 2022. "The Expanding Spectrum of FLNC Cardiomyopathy" Cardiogenetics 12, no. 4: 276-277. https://doi.org/10.3390/cardiogenetics12040027
APA StyleMonda, E., Caiazza, M., & Limongelli, G. (2022). The Expanding Spectrum of FLNC Cardiomyopathy. Cardiogenetics, 12(4), 276-277. https://doi.org/10.3390/cardiogenetics12040027